Immunosuppressive effects of vascular endothelial growth factor

Vascular endothelial growth factor (VEGF) serves a critical role in vasculogenesis, angiogenesis, tumor, inflammatory angiogenesis and lymphangiogenesis. Since 2004, bevacizumab (Avastin), a humanized anti-VEGFA monoclonal antibody, has been approved for the treatment of non-small cell lung, breast,...

Descripción completa

Detalles Bibliográficos
Autor principal: Ribatti, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494354/
https://www.ncbi.nlm.nih.gov/pubmed/36238855
http://dx.doi.org/10.3892/ol.2022.13489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494354/
https://www.ncbi.nlm.nih.gov/pubmed/36238855
http://dx.doi.org/10.3892/ol.2022.13489

Ejemplares similares